TrialThe Journal of clinical endocrinology and metabolism2022

The Efficacy, Safety, and Pharmacology of a Ghrelin O-Acyltransferase Inhibitor for the Treatment of Prader-Willi Syndrome.

Jennifer L Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.